Fidelity Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.77M | Buy |
790,386
+103,649
| +15% | +$425K | ﹤0.01% | 2522 |
|
|
2025
Q4 | $2.31M | Buy |
686,737
+126,791
| +23% | +$329K | ﹤0.01% | 2556 |
|
|
2025
Q3 | $734K | Buy |
559,946
+62,744
| +13% | +$64.9K | ﹤0.01% | 2906 |
|
|
2025
Q2 | $357K | Buy |
497,202
+17,461
| +4% | +$13.7K | ﹤0.01% | 3100 |
|
|
2025
Q1 | $705K | Buy |
479,741
+176,468
| +58% | +$420K | ﹤0.01% | 2797 |
|
|
2024
Q4 | $1.34M | Buy |
303,273
+133,592
| +79% | +$542K | ﹤0.01% | 2572 |
|
|
2024
Q3 | $699K | Buy |
169,681
+34,089
| +25% | +$183K | ﹤0.01% | 2730 |
|
|
2024
Q2 | $884K | Buy |
135,592
+46,229
| +52% | +$327K | ﹤0.01% | 2559 |
|
|
2024
Q1 | $778K | Sell |
89,363
-8,486
| -9% | -$103K | ﹤0.01% | 2584 |
|
|
2023
Q4 | $1.12M | Buy |
97,849
+81,789
| +509% | +$809K | ﹤0.01% | 2443 |
|
|
2023
Q3 | $155K | Sell |
16,060
-5,084
| -24% | -$49.8K | ﹤0.01% | 2965 |
|
|
2023
Q2 | $225K | Buy |
21,144
+2,154
| +11% | +$23.1K | ﹤0.01% | 2913 |
|
|
2023
Q1 | $200K | Sell |
18,990
-248
| -1% | -$2.78K | ﹤0.01% | 2983 |
|
|
2022
Q4 | $238K | Sell |
19,238
-80,247
| -81% | -$910K | ﹤0.01% | 2959 |
|
|
2022
Q3 | $1.03M | Buy |
99,485
+73,335
| +280% | +$831K | ﹤0.01% | 2600 |
|
|
2022
Q2 | $301K | Sell |
26,150
-16,443
| -39% | -$194K | ﹤0.01% | 3011 |
|
|
2022
Q1 | $536K | Buy |
42,593
+36,736
| +627% | +$421K | ﹤0.01% | 2967 |
|
|
2021
Q4 | $68K | Sell |
5,857
-387
| -6% | -$4.75K | ﹤0.01% | 3169 |
|
|
2021
Q3 | $82K | Sell |
6,244
-412
| -6% | -$5.33K | ﹤0.01% | 3117 |
|
|
2021
Q2 | $86K | Sell |
6,656
-284,827
| -98% | -$3.26M | ﹤0.01% | 3059 |
|
|
2021
Q1 | $3.26M | Sell |
291,483
-1,009,405
| -78% | -$10.7M | ﹤0.01% | 2363 |
|
|
2020
Q4 | $14.8M | Sell |
1,300,888
-2,533,508
| -66% | -$27.7M | ﹤0.01% | 1833 |
|
|
2020
Q3 | $34.5M | Sell |
3,834,396
-1,686,562
| -31% | -$16.8M | ﹤0.01% | 1337 |
|
|
2020
Q2 | $57M | Sell |
5,520,958
-5,535,755
| -50% | -$56.7M | 0.01% | 1111 |
|
|
2020
Q1 | $112M | Buy |
11,056,713
+251,724
| +2% | +$2.96M | 0.02% | 711 |
|
|
2019
Q4 | $144M | Sell |
10,804,989
-616,439
| -5% | -$6.8M | 0.02% | 772 |
|
|
2019
Q3 | $98.1M | Sell |
11,421,428
-2,405,546
| -17% | -$23.4M | 0.01% | 902 |
|
|
2019
Q2 | $151M | Sell |
13,826,974
-3,587,897
| -21% | -$40.2M | 0.02% | 749 |
|
|
2019
Q1 | $197M | Sell |
17,414,871
-36,635
| -0.2% | -$409K | 0.02% | 656 |
|
|
2018
Q4 | $151M | Sell |
17,451,506
-2,744,986
| -14% | -$31.5M | 0.02% | 689 |
|
|
2018
Q3 | $312M | Sell |
20,196,492
-1,401,177
| -6% | -$22.1M | 0.04% | 488 |
|
|
2018
Q2 | $346M | Buy |
21,597,669
+653,982
| +3% | +$9.68M | 0.04% | 447 |
|
|
2018
Q1 | $271M | Sell |
20,943,687
-125,557
| -0.6% | -$1.56M | 0.03% | 563 |
|
|
2017
Q4 | $265M | Sell |
21,069,244
-1,051,310
| -5% | -$13.7M | 0.03% | 580 |
|
|
2017
Q3 | $292M | Sell |
22,120,554
-223,083
| -1% | -$3.07M | 0.04% | 528 |
|
|
2017
Q2 | $353M | Sell |
22,343,637
-794,705
| -3% | -$11.5M | 0.04% | 442 |
|
|
2017
Q1 | $331M | Sell |
23,138,342
-352,605
| -2% | -$4.82M | 0.04% | 471 |
|
|
2016
Q4 | $301M | Buy |
23,490,947
+219,882
| +0.9% | +$2.78M | 0.04% | 493 |
|
|
2016
Q3 | $310M | Buy |
23,271,065
+260,692
| +1% | +$3.05M | 0.04% | 476 |
|
|
2016
Q2 | $252M | Buy |
23,010,373
+183,375
| +0.8% | +$1.79M | 0.03% | 566 |
|
|
2016
Q1 | $209M | Sell |
22,826,998
-303,548
| -1% | -$2.5M | 0.03% | 629 |
|
|
2015
Q4 | $225M | Sell |
23,130,546
-82,148
| -0.4% | -$794K | 0.03% | 606 |
|
|
2015
Q3 | $203M | Sell |
23,212,694
-360,370
| -2% | -$3.36M | 0.03% | 624 |
|
|
2015
Q2 | $238M | Sell |
23,573,064
-15,522
| -0.1% | -$180K | 0.03% | 612 |
|
|
2015
Q1 | $316M | Hold |
23,588,586
| – | – | 0.04% | 490 |
|
|
2014
Q4 | $303M | Sell |
23,588,586
-13,100
| -0.1% | -$150K | 0.04% | 482 |
|
|
2014
Q3 | $256M | Hold |
23,601,686
| – | – | 0.03% | 541 |
|
|
2014
Q2 | $303M | Hold |
23,601,686
| – | – | 0.04% | 486 |
|
|
2014
Q1 | $244M | Buy |
23,601,686
+5,833,589
| +33% | +$65.6M | 0.03% | 569 |
|
|
2013
Q4 | $173M | Buy |
17,768,097
+17,075
| +0.1% | +$153K | 0.02% | 702 |
|
|
2013
Q3 | $176M | Buy |
17,751,022
+210,502
| +1% | +$2.07M | 0.03% | 676 |
|
|
2013
Q2 | $146M | Buy |
+17,540,520
| New | +$213M | 0.02% | 727 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Fidelity Investments's IRWD Position: Q1 2026 in Review
Fidelity Investments increased its Ironwood Pharmaceuticals (IRWD) stake by 15% in Q1 2026, buying an estimated $425K and bringing the position to 790,386 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2522.
Fidelity Investments first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $353M in Q2 2017. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Fidelity Investments held 790,386 shares of Ironwood Pharmaceuticals worth $2.77M as of Q1 2026.
- Fidelity Investments bought 103,649 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $425K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2522 holding.
- Fidelity Investments first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Ironwood Pharmaceuticals position peaked at $353M in Q2 2017.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.